Evidence map›Paper›PMID 38207124›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2024

Latent Tuberculosis Infection Testing Practices in a Large US Integrated Healthcare System.

Jennifer H Ku, Heidi Fischer, Lei X Qian, Kris Li, Jacek Skarbinski, Sally Shaw, Katia J Bruxvoort, Bruno J Lewin, Brigitte C Spence, Sara Y Tartof

Open access · bronzeAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Uncovering Household Tuberculosis Infection Testing and Care Patterns Using a Novel Bioinformatics Linkage Strategy.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Improving tuberculosis infection treatment completion among pregnant and postpartum women.Journal of clinical tuberculosis and other mycobacterial diseases · 2025
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Jennifer H KuDepartment of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.ORCID 0000-0001-9469-5875
Heidi FischerDepartment of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.
Lei X QianDepartment of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.
Kris LiDepartment of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.
Jacek SkarbinskiDivision of Research, Kaiser Permanente Northern California, Oakland, California, USA.
Sally ShawDepartment of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.
Katia J BruxvoortDepartment of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.
Bruno J LewinDepartment of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.
Brigitte C SpenceDepartment of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.
Sara Y TartofDepartment of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.ORCID 0000-0003-2336-8476
Kaiser Permanente · US

Funding

A New Approach to an Old Problem: Redesigning Latent Tuberculosis Screening and TreatmentR01AI151072 · NIAID · KAISER FOUNDATION RESEARCH INSTITUTE · PI TARTOF, SARA · 2020 to 2024
$3.9M
CDCNIAID NIH HHS R01 AI151072NIH HHS 5R01AI151072
6 · The paper itself

Abstract

backgroundTuberculosis (TB) is a public health threat, with >80% of active TB in the United States occurring due to reactivation of latent TB infection (LTBI). We may be underscreening those with high risk for LTBI and overtesting those at lower risk. A better understanding of gaps in current LTBI testing practices in relation to LTBI test positivity is needed.

methodsThis study, conducted between 1 January 2008 and 31 December 2019 at Kaiser Permanente Southern California, included individuals aged ≥18 years without a history of active TB. We examined factors associated with LTBI testing and LTBI positivity.

resultsAmong 3 816 884 adults (52% female, 37% White, 37% Hispanic, mean age 43.5 years [standard deviation, 16.1]), 706 367 (19%) were tested for LTBI, among whom 60 393 (9%) had ≥1 positive result. Among 1 211 971 individuals who met ≥1 screening criteria for LTBI, 210 025 (17%) were tested for LTBI. Factors associated with higher adjusted odds of testing positive included male sex (1.32; 95% confidence interval, 1.30-1.35), Asian/Pacific Islander (2.78, 2.68-2.88), current smoking (1.24, 1.20-1.28), diabetes (1.13, 1.09-1.16), hepatitis B (1.45, 1.34-1.57), hepatitis C (1.54, 1.44-1.66), and birth in a country with an elevated TB rate (3.40, 3.31-3.49). Despite being risk factors for testing positive for LTBI, none of these factors were associated with higher odds of LTBI testing.

conclusionsCurrent LTBI testing practices may be missing individuals at high risk of LTBI. Additional work is needed to refine and implement screening guidelines that appropriately target testing for those at highest risk for LTBI.

Indexed as

Delivery of Health Care, IntegratedLatent TuberculosisMass ScreeningAdolescentAdultAgedCaliforniaFemaleHumansMaleMiddle AgedRisk FactorsUnited StatesYoung Adultgamma interferon release assaylatent tuberculosis infectionlatent tuberculosis screeningtuberculin skin test

Identifiers

PMID38207124
PMCPMC11093665
OpenAlexW4390788046

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.